Vanda Pharmaceuticals
VNDA
VNDA
179 hedge funds and large institutions have $967M invested in Vanda Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 81 increasing their positions, 44 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
28% less capital invested
Capital invested by funds: $1.34B → $967M (-$378M)
32% less call options, than puts
Call options by funds: $1.44M | Put options by funds: $2.13M
Holders
179
Holding in Top 10
3
Calls
$1.44M
Puts
$2.13M
Top Buyers
| 1 | +$22.1M | |
| 2 | +$19.1M | |
| 3 | +$16.5M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$10.4M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$5.79M |
Top Sellers
| 1 | -$36.6M | |
| 2 | -$14.2M | |
| 3 | -$10.3M | |
| 4 |
CCM
Consonance Capital Management
New York
|
-$7.37M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$6.01M |